The VA RR&D Center for Neurorestoration and Neurotechnology (CfNN) Leadership - VA Providence Healthcare System
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Providence Healthcare System


The VA RR&D Center for Neurorestoration and Neurotechnology (CfNN) Leadership

 Leigh R. Hochberg, MD, PhD, FAAN, FANA

Dr. Hochberg is Director of the VA RR&D Center for Neurorestoration and Neurotechnology (CfNN), and is a vascular and critical care neurologist and neuroscientist. His research focuses on the development and testing of novel neurotechnologies to help people with paralysis and other neurologic disorders, and on understanding cortical neuronal ensemble activities in humans. In addition to his role at CfNN, Dr. Hochberg has appointments as Professor of Engineering, School of Engineering and Carney Institute for Brain Science, Brown University; Neurologist, Massachusetts General Hospital, where he attends in the NeuroICU and on the Acute Stroke service; and Senior Lecturer on Neurology at Harvard Medical School. He also directs the Center for Neurotechnology and Neurorecovery for MGH Neurology, where he is the IDE Sponsor-Investigator and Principal Investigator of the BrainGate pilot clinical trials ( that are conducted by a close collaboration of clinicians, scientists, and engineers at Providence VAMC, Brown, Case Western Reserve University, MGH, and Stanford University. Dr. Hochberg is a Fellow of the American Academy of Neurology and the American Neurological Association. Dr. Hochberg’s BrainGate research, which has been published Nature, Science Translational Medicine, Nature Medicine, Nature Neuroscience, the Journal of Neuroscience, the Journal of Neural Engineering, and others, is supported by the Rehabilitation R&D Service of the U.S. Department of Veterans Affairs, and the National Institutes of Health including NCMRR/NICHD, NIDCD, NINDS, and the BRAIN Initiative.

 Benjamin D. Greenberg, MD, PhD Dr. Greenberg is the Associate Director of CfNN. He received a BA in Psychology from Amherst College, a PhD in Neurosciences from the University of California, San Diego, and an MD from the University of Miami. Since joining CfNN in 2013, noninvasive neuromodulation has become a major focus of interest. These methods include Transcranial Magnetic Stimulation (TMS) and transcranial DC and AC electrical stimulation (tDCS and tACS). The work focuses on testing device-based treatments in chronic pain, Post-Traumatic Stress Disorder (PTSD), as well as Obsessive-Compulsive Disorder (OCD) and Tourette syndrome. For pain, a research goal is reducing the suffering associated with chronic pain by modulating the relevant brain circuitry. Across conditions, the effort aims to develop brain stimulation methods to improve the response to behavioral therapies for Veterans with chronic pain, PTSD, OCD or Tourette syndrome. The CfNN, together with resources at Brown University and its affiliated hospitals, provides the environment for collaborative translational research using brain stimulation, neuroimaging, neuroanatomy, neurophysiology, and cognitive neuroscience to better understand the neurocircuitry of these and other illnesses with the ultimate goals of enhancing rehabilitation and relieving suffering in Veterans and others affected by these serious conditions.
 Kate Barnabe, MHA Kate Barnabe is the Administrative officer for the VA Center for Neurorestoration and Neurotechnology (CfNN).  Ms. Barnabe holds a Bachelor’s Degree in Psychology and a Master of HealthCare Administration from Simmons University in Boston, MA. She has over fifteen years of research experience in drug and device studies.  Prior to joining CfNN, Ms. Barnabe served as Supervisory Program Specialist for Dr. Linda Resnik’s Prosthetics and Orthotics Research Laboratory as well as Project Coordinator of the multi-site studies of the DEKA Arm. Kate began her research career with the Translational Pain Research Program at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston, MA, where she served as both Lead Study Coordinator and Program Coordinator for over 20 single center and multi-site Phase I-III clinical trials.

* These links are regular email and are not secure.  Do not send personal or medical information over the internet.
** Link takes you outside of the Department of Veterans Affairs Website.  VA does not endorse and is not responsible for the content of the linked website.